DUBLIN--(BUSINESS WIRE)--The "Alpha Emitters Market Analysis, By Radionuclide Type (Bismuth, Astatine, Radium), By Medical Application, By End User, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The alpha emitters market size is estimated to be USD 698.3 million in 2021 and is expected to witness a CAGR of 35.82% during the forecast period 2022-2029. The increased public knowledge of the potential advantages of targeted alpha emitters and the prevalence of several malignancies, including ovarian, pancreatic, lymphoma, and melanoma are factors contributing to the market growth. However, stringent regulatory requirement is expected to hinder the growth.
Segmentation: Alpha Emitters Market Report 2021-2029
Radionuclide Type (Revenue, USD Million)
- Bismuth (Bi-212)
- Astatine (At-211)
- Radium (Ra-223)
- Actinium (Ac-225)
- Bismuth (Bi -213)
- Lead (Pb-212)
- Terbium (Tb-149)
Medical Application (Revenue, USD Million)
- Pancreatic Cancer
- Prostate Cancer
- Endocrine Tumors
- Ovarian Cancer
- Bone Metastases
- Others
End user (Revenue, USD Million)
- Clinics
- Hospitals
- Research Laboratories
By Region (Revenue, USD Million)
North America
- U.S
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Key Topics Covered:
1. Research Methodology
2. Introduction: Alpha Emitters
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Alpha Emitters Market
7. Market Analysis by Radionuclide Type
8. Market Analysis by Medical Application
9. Market Analysis by End User
10. Regional Market Analysis
11. North America Alpha Emitters Market
12. Europe Alpha Emitters Market
13. Asia Pacific Alpha Emitters Market
14. Latin America Alpha Emitters Market
15. MEA Alpha Emitters Market
16. Competitor Analysis
17. Company Profiles
18. Conclusion & Recommendations
Companies Mentioned
- Bracco Imaging (Italy)
- Eczacybaşy-Monrol Nuclear Products (Turkey)
- Nordion (Canada)
- GE Healthcare (US)
- Advanced Accelerator Applications (France)
- Lantheus Medical Imaging (US)
- NTP Radioisotopes (South Africa)
- Curium (France)
- JSC Isotope (Russia)
- Cardinal Health (US)
- Bayer AG (Germany)
- NorthStar Medical Radioisotopes (US)
- Eckert & Ziegler (Germany)
For more information about this report visit https://www.researchandmarkets.com/r/78tbtz
